Search

Your search keyword '"Jennings, Nicholas B."' showing total 307 results

Search Constraints

Start Over You searched for: Author "Jennings, Nicholas B." Remove constraint Author: "Jennings, Nicholas B."
307 results on '"Jennings, Nicholas B."'

Search Results

1. Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

2. Enhancing oral delivery of plant-derived vesicles for colitis

Catalog

Books, media, physical & digital resources

6. CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

8. Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype

9. Mechanism and rational combinations with GP‐2250, a novel oxathiazine derivative, in ovarian cancer.

12. Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

14. ATP11B mediates platinum resistance in ovarian cancer

15. Abstract 2720: Enhancing oral delivery of plant-derived vesicles

16. Data from Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

17. Data from Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment

18. Supplementary Figures from Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

19. Data from Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

20. Supplementary Figures 1-6 from Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

21. Supplementary Figures 1-12 from Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment

22. Supplementary Tables 1-2 from Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment

23. Figure S1 from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

24. Supplementary data from Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

25. Data from Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

26. Supplementary Figures 1 - 3 from Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

27. Supplementary Data from EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

28. Supplementary Video 1 from Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

29. Supplementary Video 2 from Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

30. Supplementary Figure 1 from Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma

31. Supplementary Video 3 from Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

32. Data from Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

33. Supplemental Figures 1-4 from Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

34. Supplementary Figures 1 - 6 and Tables 1 - 10 from Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib

35. Supplementary Figure 2 from Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

36. Supplementary Figure 1 from Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

37. Supplementary information from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

38. Supplementary Data from Therapeutic Targeting of ATP7B in Ovarian Carcinoma

39. Supplementary Methods from Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

40. Supplementary Figure 3 from Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

41. Supplementary Figure 2 from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

42. Supplementary Table 1 from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

43. Data from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

44. Supplementary Table 2 from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

45. Supplementary Figure 1 from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

46. Supplementary Table 3 from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

47. Supplementary Methods, Legends for Tables 1-3, Figures 1--2 from Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

48. Endothelial p130cas confers resistance to anti-angiogenesis therapy

49. Biologic Effects of Dopamine on Tumor Vasculature in Ovarian Carcinoma

50. Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer